Use case scenarios for potential COVID-19 vaccines
Join us for the second seminar in the Let’s Talk COVID-19 series where Professor Annelies Wilder-Smith will discuss the potential for COVID-19 vaccines.
The speed with which a potential COVID-19 vaccine is being developed is remarkable due to parallel efforts of diverse platforms and high-risk early upscaling of manufacturing capabilities. In addition, early deliberations are underway that will shape policy formulations based on target product profiles and anticipated optimum impact especially in the context of constrained vaccine supply.
- Chair: Hilary Bower, Assistant professor in Epidemiology, UK Public Health Rapid Support Team
- Speaker: Annelies Wilder-Smith, Professor of Emerging Infectious Diseases, LSHTM
- Discussant: Professor Daniel Bausch, Director, UK Public Health Rapid Support Team
About the Speaker
Annelies Wilder-Smith is Professor of Emerging Infectious Diseases at the London School of Hygiene and Tropical Medicine and Consultant to WHO on vaccine policies. She is the Past President of the International Society of Travel Medicine, Chair of the Lancet Commission on Dengue and other Arboviral Diseases, and co-Chair of the Lancet ID Commission on Pandemic Preparedness.
Developing Covid-19 Vaccines at Pandemic Speed. Lurie N, Saville M, Hatchett R, Halton J. N Engl J Med. 2020 May 21;382(21):1969-1973. doi: 10.1056/NEJMp2005630. Epub 2020 Mar 30.
LSHTM's response to COVID-19
LSHTM experts are involved in many different aspects of COVID-19 research as well as providing guidance to those responding around the globe every day. Find out about our latest research, news, events and free online courses on the outbreak.
Subscribe to our new LSHTM Viral podcast to hear the latest science behind the coronavirus outbreak and the global response to COVID-19. You can listen to LSHTM Viral wherever you get your podcasts: Anchor, Apple Podcasts, Breaker, Castbox, Google Podcasts, Overcast, Pocket Casts, RadioPublic, Spotify, Stitcher.
There cannot be any complacency as to the need for global action. With your help, we can plug critical gaps in the understanding of COVID-19. This will support global response efforts and help to save lives around the world. Support LSHTM's COVID-19 Response Fund.